Lan Zhu

(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Dooseop Kim, Liping Wang, Maria Beconi et al. · Journal of Medicinal Chemistry · 2004 · 808 citations · Full text

A Single <i>IGF1</i> Allele Is a Major Determinant of Small Size in Dogs

Nathan B. Sutter, Carlos D. Bustamante, Kevin Chase et al. · Science · 2007 · 669 citations · Full text

Genetics, Genomic Selection, Animal Genetics +18

Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes

George R. Lankas, Barbara Leiting, Ranabir Sinha Roy et al. · Diabetes · 2005 · 490 citations · Full text

Diabetes Management, Pharmacological Study, Biochemistry +15

Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic β-Cell Mass and Function in a Rodent Model of Type 2 Diabetes

James Mu, John Woods, Yun-Ping Zhou et al. · Diabetes · 2006 · 450 citations · Full text

Dipeptidyl Peptidase-4, Insulin Signaling, Gastrointestinal Peptide Hormone +17

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

Alessandro Pocai, Paul E. Carrington, Jennifer R. Adams et al. · Diabetes · 2009 · 405 citations · Full text